Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Ph. 1b patients #5 and #6 still cancer free after 2 years

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Aug 23, 2022 1:13pm

148 Views

Post# 34914679

RE:Ph. 1b patients #5 and #6 still cancer free after 2 years

To put people through TURBT and high side effect immuno franken drugs seems almost barbaric when you consider the elegant manner in which the TLT process and TLD1433 drug eliminates cancerous cells. Once thousands of people have had our treatment, the BCG/Keytruda path will seem like a bad dream.

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth